iSportz

Game-Changing Solutions: iSportz Modernizes Sports Management, Engagement, and Entertainment

Whether it is professionals or little 4-year-olds kicking soccer balls down a field, sports have everything: action, excitement, drama, and most importantly, FUN; unfortunately, the current management processes and tools for sporting events aren't so much fun. The way sports events are managed presents a number of challenges that minimize the participant and spectator ease and enjoyment as well as cause event organizers to pull their hair out with the inefficiencies, errors, and missed opportunities.


The Flossing Dilemma Solved: Instafloss' Innovative Approach

When it comes to taking care of our teeth, there's a huge difference between what we know we should do and what we actually do, especially when it comes to flossing. It's that one thing dentists remind us to do, but many of us just don't. In fact, only 30% of the US population reported using floss daily, leaving 70% of Americans who rarely floss or don't do it at all, according to the US News and World Report.

Healwell AI Announces Record Quarterly Revenue, Expands Strategic Alliances

Healwell AI Inc. has announced its interim consolidated financial results for the first quarter ended March 31, 2024. The company reported a jump in quarterly revenue from continuing operations to $4.58 million, marking a 132% increase compared to the same period in 2023. This surge in revenue reflects the company's robust growth trajectory since its relaunch and strategic acquisitions.

Trump Media and Technology Group, Truth Social's Parent Company, Lost Over $300 Million, First Earning Report Reveals

In its first quarter since going public, Trump Media & Technology Group, the company that owns Truth Social, reported a concerning loss and revenue of less than $1 million.


Latest News

JPMorgan Chase CEO Jamie Dimon Preparing to Retire Sooner Than Expected, Striking Key Change in Plans
JPMorgan Chase CEO Jamie Dimon suggested that he may resign as the leader of the country's biggest lender earlier than expected.
Whistleblower Claims GlaxoSmithKline Lies to FDA, Federal Government About Zantac Safety Claims
A whistleblower has come out with allegations that GlaxoSmithKline (GSK) deceived the public about the safety of Zantac, a popular heartburn medicine.
US Water Utilities Targeted by Cyberattacks; EPA Warns Cyberbreaches Becoming More Severe, Frequent
US water utilities are targeted by cyberattacks more frequently. EPA warns that the cyberattacks are becoming more severe as well.
BMW Recalls Over 390,000 US Cars Over Potential Issues With Takata Airbags
The US Senate accuses BMW and other automakers of buying car components from a banned Chinese supplier. Here's what officials shared.
2 Chinese Nationals Convicted for Multimillion-Dollar Scheme to Dupe Apple Out of 5,000 iPhones
Apple is aggressively discounting select iPhone models in China, offering up to a $360 price reduction on its official Tmall site. It aims to compete with local rivals like Huawei, which is under pressure from its new smartphone series, the Pura 70.
Volkswagen Door Flaw Leads To Mass Recall; US NHTSA Says Over 50,000 EVs Affected
Volkswagen's door flaw concerns the U.S. NHTSA. Because of this, over 50,000 EVs are estimated to be affected by the mass recall.
FRANCE-AVIATION-ECONOMY
Saudia Group has placed a historic order for 105 Airbus narrow-body aircraft, valued at $19 billion. Deliveries will start in 2026 and conclude in 2032.
Red Lobster Abruptly Closes Many Locations
Red Lobster has filed for Chapter 11 bankruptcy protection, citing high operational costs and an unprofitable unlimited shrimp promotion. It plans to transfer control to its lenders with $100 million in financing from Fortress Investment Group.
Elon Musk's Neuralink Seeks Second Person to Test Brain Chip After US FDA Gives Green Light
The US Food and Drug Administration granted Elon Musk's Neuralink permission to implant its brain chip in a second person, approving the company's suggested solutions for an issue that arose in the first test subject.
Keir Starmer and Peter Kyle Visit The AstraZeneca Laboratory In Macclesfield
AstraZeneca will build a $1.5 billion manufacturing facility in Singapore to produce antibody-drug conjugates (ADCs) and targeted cancer therapies. This will be the company's first end-to-end ADC production site and will receive support from the Singapore Economic Development Board (EDB).
  74 75 76 77 78 79 80 81 82